DURECT Corporation (NASDAQ: DRRX)
$0.9597
-0.0103 ( +7.83% ) 62.3K
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Market Data
Open
$0.9597
Previous close
$0.9700
Volume
62.3K
Market cap
$30.11M
Day range
$0.8820 - $0.9750
52 week range
$0.5079 - $1.8800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k/a | 8K-related | 12 | Nov 29, 2024 |
8-k | 8K-related | 12 | Nov 25, 2024 |
10-q | Quarterly Reports | 63 | Nov 14, 2024 |
8-k | 8K-related | 12 | Nov 13, 2024 |
4 | Insider transactions | 1 | Oct 16, 2024 |
4 | Insider transactions | 1 | Oct 16, 2024 |
4 | Insider transactions | 1 | Oct 16, 2024 |
4 | Insider transactions | 1 | Sep 27, 2024 |
4 | Insider transactions | 1 | Sep 27, 2024 |
4 | Insider transactions | 1 | Sep 27, 2024 |